From Surf Wiki (app.surf) — the open knowledge base
Argininemia
| Field | Value |
|---|---|
| name | Argininemia |
| image | Arginin_-_Arginine.svg |
| alt | 2D chemical structure of arginine |
| caption | Arginine |
| symptoms | Lethargy, Dehydration |
| synonyms | Arginase deficiency |
| causes | Mutations in the ARG1 gene |
| diagnosis | Urinary orotic acid concentration |
| treatment | Limited protein intake, sodium benzoate |
Argininemia is an autosomal recessive urea cycle disorder where a deficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Ammonia, which is formed when proteins are broken down in the body, is toxic if levels become too high; the nervous system is especially sensitive to the effects of excess ammonia.
Signs and symptoms
The presentation of argininemia, in those that are affected, is consistent with the following:
- Lethargy
- Dehydration
- Hypotonia
- Stunted growth
- Microcephaly
- Seizures
Genetics
Mutations in the ARG1 gene cause argininemia, which belongs to a class of genetic diseases called urea cycle disorders. The urea cycle is a sequence of reactions that occurs in liver cells (hepatocytes). This cycle processes excess nitrogen, generated when protein is used by the body, making urea that is excreted via the kidneys.
The ARG1 gene provides instructions for making an enzyme called arginase, this enzyme controls the last steps of the urea cycle, which produces urea by extracting nitrogen from arginine. In people with arginase deficiency, arginase is missing, and arginine is not broken down properly. consequently, urea cannot be produced and excess nitrogen accumulates in the blood in the form of ammonia. Ammonia and arginine are thought to cause neurological problems and other symptoms of arginase deficiency.
This condition is an autosomal recessive disorder, which means the defective gene is located on an autosome, and two copies of the defective gene are required to inherit the disorder.
Both parents of an individual with an autosomal recessive disorder are carriers of one copy of the gene, but usually do not have the disorder.
Diagnosis
The diagnosis for argininemia can usually be done using fetal blood sample. One can look for the following indicators as to the presence of the condition:
- Plasma ammonia concentration.
- Urinary orotic acid concentration
- Red blood cell arginase enzyme activity (measurement)
Treatment
The treatment for people with argininemia includes:
- Sodium benzoate
- Sodium phenylbutyrate
- Carglumic acid
- Glycerol phenylbutyrate
- Palonosetron
- Ondansetron hydrochloride
Pegzilarginase (Loargys) was approved for medical use in the European Union in December 2023.
References
References
- {{OMIM. 207800
- (1 January 1993). "Arginase Deficiency". GeneReviews.
- "Arginase deficiency". [[National Library of Medicine]].
- (15 April 2016). "Arginase Deficiency: Background, Pathophysiology, Epidemiology".
- "ARG1 gene".
- (1 January 1993). "Urea Cycle Disorders Overview". GeneReviews.
- (2005). "Instant Notes in Biochemistry.". Taylor & Francis Ltd..
- (2015). "Pediatric Gastrointestinal and Liver Disease". Elsevier Health Sciences.
- (18 December 2023). "Loargys Product information".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Argininemia — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report